Research output per year
Research output per year
Fingerprint
Dive into the research topics where Alessandra Oliva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study
Tumbarello, M., Raffaelli, F., Giannella, M., Mantengoli, E., Mularoni, A., Venditti, M., De Rosa, F. G., Sarmati, L., Bassetti, M., Brindicci, G., Rossi, M., Luzzati, R., Grossi, P. A., Corona, A., Capone, A., Falcone, M., Mussini, C., Trecarichi, E. M., Cascio, A., Guffanti, E. & 25 others, , Nov 1 2021, In: Clinical Infectious Diseases. 73, 9, p. 1664-1676 13 p.Research output: Contribution to journal › Article › peer-review
-
Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia
The ReCOVeRI Study Group, Dec 2021, In: Scientific Reports. 11, 1, p. 1-10 10 p., 11334.Research output: Contribution to journal › Article › peer-review
Open Access -
Prospective study on incidence, risk factors and outcome of recurrent clostridioides difficile infections
ReCloDi (Recurrence of Clostridioides difficile Infection) Study Group, Mar 1 2021, In: Journal of Clinical Medicine. 10, 5, p. 1-11 11 p., 1127.Research output: Contribution to journal › Article › peer-review
Open Access -
Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital
For the INMI Recovery study group, Apr 2021, In: International Journal of Infectious Diseases. 105, p. 532-539 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical experience with ceftazidime-avibactam for the treatment of infections due to multidrug-resistant gram-negative bacteria other than carbapenem-resistant Enterobacterales
CEFTABUSE study group, Feb 2020, In: Antibiotics. 9, 2, 71.Research output: Contribution to journal › Article › peer-review
Open Access